A Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Phase of Trial: Phase II
Latest Information Update: 08 May 2019
At a glance
- Drugs Irinotecan (Primary) ; Temozolomide (Primary) ; Temozolomide (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Ifosfamide; Vincristine
- Indications Ewing's sarcoma
- Focus Therapeutic Use
- 17 Oct 2018 Planned number of patients changed from 83 to 93.
- 06 Aug 2018 Planned End Date changed from 1 May 2019 to 1 May 2020.
- 06 Aug 2018 Planned primary completion date changed from 1 May 2019 to 1 May 2020.